Karyopharm Therapeutics (KPTI) Accounts Payables (2012 - 2026)
Karyopharm Therapeutics (KPTI) recorded Accounts Payables of $7.66 million in Q2 2026, up 195.0% from $2.6 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Accounts Payables (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics reported Accounts Payables of $4 million, down 21.6% from FY2024.
- Annual Accounts Payables has a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
- Across earlier years, Accounts Payables came in at $5.11 million in FY2024 (+63.5%), $3.12 million in FY2023 (+12.6%), $2.77 million in FY2022 (+73.0%) and $1.6 million in FY2021 (-64.0%).
- The Q2 2026 figure is the highest quarterly Accounts Payables since Q1 2023.
- On a year-over-year basis, Accounts Payables rose in four of the last seven quarters, with growth averaging 107.6%.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 513.3% in Q3 2024, against a decline of 64.0% in Q4 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Karyopharm Therapeutics | 15.99 Mn | -210.43 Mn | 32.35 Mn | 7.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.66 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 5.39 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 5.87 Mn |
| Dec 31, 2024 | 5.11 Mn |
| Sep 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Dec 31, 2023 | 3.12 Mn |
| Sep 30, 2023 | 943,000.00 |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 9.05 Mn |
| Dec 31, 2022 | 2.77 Mn |
| Sep 30, 2022 | 813,000.00 |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 3.44 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 881,000.00 |
| Jun 30, 2021 | 2.31 Mn |
API Access
Karyopharm Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();